In The Media
DIA 2023: PALADIN Brings Patient Advocacy and Industry Together
In this interview, Vicky DiBiaso, Global Head, Patient Informed Development & Health Value Translation at Sanofi and Kenneth Getz, Executive Director/Professor, Tufts CSDD and Founder/Board Chair, CISCRP, discuss the formation, mission and goals for PALADIN.
Introducing PALADIN — Applied Clinical Trials
In the spring of 2023, Sanofi provided thought leadership and funding to launch a pre-competitive, disease-agnostic Consortium whose mission is to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.
Sanofi launches R&D Consortium of industry and patient advocacy groups to accelerate medicines development
First-of-its-kind consortium brings together advocacy and industry organizations to address efficiencies across disease types that have the potential to speed the development of medicines for patients.